that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

The lung cancer surgery market represents a critical segment within the broader oncology and surgical treatment industry. Lung cancer remains one of the most prevalent and deadly cancers worldwide, ...

Doctors and researchers are constantly working to find new ways to catch cancers earlier, and help you beat it if it happens.

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people ...

A mother-of-two from Carlisle says she has been given her life back after receiving targeted cancer treatment.

Amgen has detailed a positive phase 3 readout for its T-cell engager Imdelltra in previously treated small cell lung cancer ...